Pharma Times

NOVEMBER 10, 2020

RECOVERY study will assess if drug can reduce risk of blood clots

153

153

NY Times

NOVEMBER 10, 2020

The German company BioNTech, founded by two scientists, has teamed up with Pfizer on a vaccine that was found to be more than 90 percent effective.

Vaccines 145

Vaccines 145

pharmaphorum

NOVEMBER 11, 2020

Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment. With AI already the key engine for a growing list of consumer devices, the trend has created exciting opportunities for pharma and healthcare. “We have now entered a new phase of AI implementation where AI-based technology is expected to be foundational and not just a novel technology,” Abid Rahman, vice president, innovation,

Pharmaceutical Companies 139

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 139

Outsourcing Pharma

NOVEMBER 12, 2020

A leader from the AI technology firm discusses how life-sciences pros are harnessing AI to help continue their work in the face of the pandemic.

139

139

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

NOVEMBER 9, 2020

Conclusions made by a group of experts from academia and industry

149

149

Drug Patent Watch

NOVEMBER 10, 2020

We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits. If your colleagues would like to…. The post Thinking of signing your company up for DrugPatentWatch? appeared first on DrugPatentWatch - Make Better Decisions.

115

115

NY Times

NOVEMBER 13, 2020

A new study shows that more than half of enrollees don’t review or compare their coverage options annually.

98

98

Pharma Times

NOVEMBER 9, 2020

Phase III study of vaccine candidate involved 43,538 participants

Vaccines 137

Vaccines 137

Outsourcing Pharma

NOVEMBER 12, 2020

The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.

Drug Development 98

Drug Development 98

pharmaphorum

NOVEMBER 13, 2020

US data analysis company Palantir Technologies could be drafted in to manage the UK government’s troubled COVID-19 Test and Trace programme, according to press reports. Palantir has been linked with the project for several weeks and the Financial Times is the latest to suggest that the company could get involved with the troubled project. Palantir was founded in 2003 by a team including paypal co-founder Peter Thiel and the company’s billionaire CEO Alex Karp.

Documentation 112

Documentation 112

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

NY Times

NOVEMBER 8, 2020

Researchers ended a clinical trial of the drug early because the results were so convincing. The more effective drug would be given in six injections a year instead of as 365 daily pills.

98

98

Pharma Times

NOVEMBER 12, 2020

Company also announces new collaboration with Lacerta Therapeutics

135

135

Outsourcing Pharma

NOVEMBER 9, 2020

President-elect Joe Biden has launched a Transition COVID-19 Advisory Board to support the USâ COVID-19 response.

97

97

pharmaphorum

NOVEMBER 11, 2020

In the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Propeller Health about how digital technologies are revolutionising the field of respiratory medicine. The post Health Innovators: David Van Sickle on digital innovation in respiratory medicine appeared first on.

111

111

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

NY Times

NOVEMBER 11, 2020

La compañía alemana BioNTech, fundada por dos científicos, se ha asociado con Pfizer en una vacuna cuya eficacia se ha comprobado en más de un 90 por ciento.

98

98

Pharma Times

NOVEMBER 10, 2020

Akcea’s Waylivra approved via ultra-orphan pathway

130

130

Outsourcing Pharma

NOVEMBER 10, 2020

The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.

Diabetes 89

Diabetes 89

pharmaphorum

NOVEMBER 9, 2020

Novo Nordisk has agreed to buy Emisphere Technologies for $1.8 billion, as it continues its quest to develop diabetes medicines that can be taken as pills. Copenhagen-based Novo Nordisk already markets Rybelsus (semaglutide), a version of its GLP-1 class drug that can help to control blood sugar levels in patients with type 2 disease. But the company has tried and failed to produce insulin that can be taken orally – this proved unfeasible due to the high doses of the hormone that were needed for

Diabetes 111

Diabetes 111

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

NY Times

NOVEMBER 9, 2020

The authorization raised immediate questions about who would get access to the antibody treatments, which are in short supply.

98

98

Pharma Times

NOVEMBER 12, 2020

Study will collect real-world data on use of INOmax in COVID-19 patients

130

130

Outsourcing Pharma

NOVEMBER 10, 2020

Preliminary results from a recent clinical trial indicate the drug touted by US leaders as a possible treatment offers no significant benefit to patients.

Hospitals 85

Hospitals 85

pharmaphorum

NOVEMBER 12, 2020

Swiss startup Synendos Therapeutics has raised CHF 20 million (almost $22 million) in first-round financing that will be used to develop its endocannabinoid drugs for central nervous system disorders. The Basel-based biotech – which was incubated in Switzerland’s BaseLaunch accelerator – is concentrating on developing a new class of small-molecule drugs for anxiety, mood and stress-related disorders.

Drug Development 106

Drug Development Compounding 106

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

NY Times

NOVEMBER 12, 2020

A major advance in the race to develop a coronavirus shot has raised hopes that mass immunization could bring an end to the pandemic.

Vaccines 96

Vaccines Immunity Immunization 96

Pharma Times

NOVEMBER 9, 2020

Industry bodies respond to Specialised Committee outcome

130

130

Outsourcing Pharma

NOVEMBER 9, 2020

According to a survey by trial solutions company Greenphire, patient recruitment and enrollment levels have bounced back since the pandemic struck.

59

59

pharmaphorum

NOVEMBER 12, 2020

CatalYm has closed a €50 million ($59m) series B financing round to fund clinical studies of its immunotherapy targeting Growth Differentiation Factor 15 (GDF-15). The round was led by Vesalius Biocapital III, with participation from Novartis Venture Fund (NVF), Wachstumsfonds Bayern, coparion and founding investors Forbion and BioGeneration Ventures.

Immunity 105

Immunity Immunization Compounding 105

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Drug Patent Watch

NOVEMBER 9, 2020

This chart shows the pharmaceutical companies with the most elixir dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most elixir dosed drugs…. The post Which pharmaceutical companies have the most elixir dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 54

Pharmaceutical Companies Pharmaceutical Companies Dosage 54

Pharma Times

NOVEMBER 11, 2020

Bamlanivimab approved for high-risk COVID-19 patients

123

123

Outsourcing Pharma

NOVEMBER 12, 2020

As the pandemic maintains a grip on the globe, the federal agency continues to offer advice and take action to guide life-sciences professionals.

58

58

pharmaphorum

NOVEMBER 12, 2020

The European Union has ordered 300 million doses of BioNTech/Pfizer’s COVID-19 vaccine following this week’s landmark announcement that it was effective in more than 90% of patients. The companies said deliveries of an initial order of 200 million vaccines will be subject to approval by European regulators and are expected to start by the end of this year.

Vaccines 105

Vaccines 105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management